Home / Economy / News / HCQ's emergency use revocation by US may not hit India's exports

HCQ's emergency use revocation by US may not hit India's exports

This is because while emergency-use authorisation for treating Covid-19 was a recent move, the drug has been used since years for rheumatoid arthritis and lupus

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical

Premium

The government source added that with the Covid-19 cases witnessing a spike, there can be fresh demand for HCQ tablets

3 min read Last Updated : Jun 16 2020 | 9:11 PM IST

Even as the US government revoked emergency use of hydroxychloroquine (HCQ) for treating coronavirus (Covid-19) patients, smaller players in India do not see much impact on export of the drug.

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis (RA) and autoimmune lupus.

“Revocation of the emergency use approval means that the drug can be reused in future when approved after a clinical study. However, the decades-old drug is used in RA and lupus which still continues. Use of HCQ for treating Covid has been

Topics : Hydroxychloroquine Drug makers in India drug manufacturer

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in